Bee-nado! Swarm warning after truck tips in Washington, setting 250 million insects free
LOS ANGELES, May 31 — A truck crash that set 250 million bees free has sparked warnings in the western US, with police telling people to avoid swarms of the stinging insects.
The accident happened in Washington state in the far northwest of the country, when a semi trailer carrying a load of hives overturned.
'250 million bees are now loose,' wrote Whatcom County Sheriff on its social media page.
'AVOID THE AREA due to the potential of bee escaping and swarming'.
Roads in the region, which nestles the border with Canada and is just 30 miles from Vancouver, have been closed as bee experts help with the clean-up.
While some beekeepers aim only to produce honey, many others rent out their hives to farmers who need the insects to pollinate their crops. — AFP
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
4 hours ago
- Malay Mail
Trump calls Netanyahu a ‘war hero', slams corruption trial as ‘witch hunt'
WASHINGTON, June 29 — President Donald Trump said yesterday the United States was 'not going to stand' for the continued prosecution of Israeli Prime Minister Benjamin Netanyahu on corruption charges. 'The United States of America spends Billions of Dollar a year, far more than on any other Nation, protecting and supporting Israel. We are not going to stand for this,' Trump posted on his Truth Social platform. An Israeli court on Friday rejected Netanyahu's request to postpone giving testimony in his corruption trial, ruling that he had not provided adequate justification for his request. In one case, Netanyahu and his wife Sara are accused of accepting more than US$260,000 (RM1 million) worth of luxury goods such as cigars, jewellery and champagne from billionaires in exchange for political favours. In two other cases, Netanyahu is accused of attempting to negotiate more favourable coverage from two Israeli media outlets. Netanyahu has denied any wrongdoing and has thanked Trump for his support in Israel's war with Iran, which saw a ceasefire agreement earlier this week. His lawyer had asked the court to excuse the leader from hearings over the next two weeks, saying he needs to concentrate on 'security issues.' Trump on Wednesday sprung to Netanyahu's defence, describing the case against him as a 'witch hunt.' Yesterday, he described Netanyahu as a 'War Hero' and said the case would distract the prime minister from negotiations with Iran and with Hamas, the Gaza-based Palestinian armed group that Israel is at war with. 'This travesty of 'Justice' will interfere with both Iran and Hamas negotiations,' said Trump, although it was unclear what negotiations he was referring to with regards to Iran. Hamas took 251 hostages during its October 7, 2023, attack on Israel, with 49 still believed to be held in Gaza, including 27 the Israeli military says are dead. Negotiations are ongoing for the return of the remaining hostages and the bodies of those killed, while Israel's punishing war on Gaza continues unabated. The US leader also likened Netanyahu's legal troubles to his own before he took office for his second term. 'It is a POLITICAL WITCH HUNT, very similar to the Witch Hunt that I was forced to endure,' said Trump. The Republican was convicted on 34 counts of falsifying business records in May 2024 in a case related to hush money payments to a porn star. Trump also faced two federal cases, one related to his alleged efforts to overturn the results of the 2020 presidential election, which he lost to Democrat Joe Biden. — AFP
Malay Mail
6 hours ago
- Malay Mail
Cheap and risky: Stung by high prices, Americans turn to DIY weight-loss drugs from the grey market
Grey market grows for cheap weight-loss drugs imported from China Some users try small doses of substances not yet approved by FDA Drugmakers call trend dangerous and illicit Online community says it's filling gaps in broken system SAN FRANCISCO, June 29 — In what she calls the 'wild west' of obesity medicines, Missouri-based Amy Spencer is a pioneer. Each week the mother of two injects herself with weight-loss drugs, two of which are in clinical trials and not yet approved for sale by the US Food and Drug Administration. One comes mixed with tirzepatide, the active ingredient in Eli Lilly's Zepbound. Spencer, 50, is not part of any drug trial but mixes the cocktails herself, using tiny doses that she believes are safe. The total cost is about US$50 (RM211) monthly, as little as one-tenth of what she would expect to pay their makers for full treatment. The drugs — glucagon-like peptide-1 (GLP-1) weight-loss medicines — are manufactured and shipped from China, according to the packaging. She orders them through online vendors. Spencer belongs to a fast-growing group of Americans turning to what many call the 'grey market' for obesity medicines, bringing cheap active ingredients from China often labelled as for research purposes, according to import data and social media postings. It's a trend that drugmakers Lilly and Novo Nordisk, which makes Wegovy, say is dangerous as well as illicit. Reuters tracked online forums and interviewed seven people who said they bought obesity medicines through this market, including an attorney in Arizona who works for a state insurance agency, a retired nurse in Illinois and a Type 1 diabetic in Louisiana, who said the medicine helped cut her insulin intake by more than half. For more than a year there has been demand for cheap Chinese-made powders, exacerbated by limited health insurance coverage in the US Buyers told Reuters the grey market received a boost from an FDA ruling last year that US compounding pharmacies — outsourcing facilities that create drugs in shortage — must stop selling obesity medicines more cheaply than the companies that developed them. Shipments of such active ingredients from Chinese entities not registered with the FDA jumped by 44 per cent in January from the previous month, according to research by the Partnership for Safe Medicines, a public health group focused on the safety of prescription drugs. It said its findings are likely an undercount, because unregistered vendors may not disclose that their parcels contain medicines. Packages valued at less than US$800 that enter the US under the de minimis rule are not included in the data. Amy Spencer holds a number of vials containing components of obesity drugs, which were purchased through the grey market, a new market for obesity drugs that allows consumers to purchase medication materials from China and reconstitute them into injectable drugs, at her home in southern Missouri April 24, 2025. — Reuters pic Nearly three-quarters of US adults are overweight or obese, according to government estimates, but a survey by nonprofit health policy research organisation KFF found only about 8 per cent say they have taken medicine for weight loss. Most of the grey market buyers Reuters interviewed had told their medical providers they were taking GLP-1 medicines but not where or how they bought them. Insurance coverage for weight-loss drugs has recently increased, but typically only covers branded versions, according to consulting firm Mercer. Many Americans have paid out of pocket for cheaper compounded drugs. Interest in taking small doses of the drugs has also spurred the online marketplace, buyers said. Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research materials to sidestep regulatory scrutiny. They swap advice for navigating the market, exchanging information on vendors, shipping and dosage, and sometimes clubbing together to cover the cost of testing the powders. One forum is called StairwayToGray. It has more than 21,000 members on Telegram and recently was gaining nearly 1,000 members weekly. It did not respond to Reuters' inquiries, and blocked access to the forum after receiving them. It has a website where it says it does not facilitate group purchases. 'This community is filling the gaps and being our own regulators, ensuring testing and access for everyone who needs it. Because you shouldn't have to choose between your health or your wallet,' it says. Spencer stores her stocks in her fridge and makes them up in the kitchen — carefully measuring sterile water, rolling the vial between her fingers until the powder dissolves, and drawing the liquid into a syringe before injecting it into her thigh or belly. She has lost 24 pounds. 'This is working so well for me. It's so easy. It's cheap,' said Spencer, who assumes her health plan wouldn't cover the drugs. 'I don't know what I would do without this medicine.' Amy Spencer poses for a portrait in a beveled bathroom mirror while holding a syringe and a vial that contained the components of obesity drugs, which she purchased through the grey market, a new market that allows consumers to purchase obesity medication materials from China and reconstitute them into injectable drugs, at her home in southern Missouri April 24, 2025. — Reuters pic 'Very dangerous' In February, 38 US state and territory attorney generals wrote the FDA seeking action against illegally sold weight-loss medicines, including 'research purposes only' ingredients from China. 'Much like with counterfeit versions, these active ingredients come from unregulated, undisclosed sources... and pose risks of contamination and inclusion of foreign substances,' they said. Shabbir Safdar, executive director of the Partnership for Safe Medicines, said unapproved drugs can have problems with sterility, purity and consistency. 'It can be very dangerous. You're playing the role of your own doctor, pharmacist, and FDA inspector,' he said. Of those interviewed, only Spencer reported any problems: She once got her math wrong and overdosed, resulting in several days of severe flu-like symptoms. Lilly said it had taken many steps to address patient safety risks posed by the proliferation of unsafe or untested tirzepatide. The company said it is filing lawsuits, educating consumers and working with social media companies to identify and remove posts that promote unsafe products, including those described as 'research use only.' 'We will continue to take action to stop those who threaten patient safety and urgently call on regulators and law enforcement to do the same,' a Lilly spokesperson told Reuters. Novo Nordisk also said it continues to take action against entities that violate laws and regulations and put patient safety at risk. America's Poison Control agency, which maintains the nation's poison data surveillance system and monitors GLP-1 exposures, said it could not reliably track cases involving unregulated 'research chemical powders' because they are sold under various names and formulations. The FDA's goal is to stop illegal sales of pharmaceutical medicines at the border, said George Karavetsos, former director of the FDA's Office of Criminal Investigations and co-author of the imports study. But understanding the true nature and intended use of small parcels arriving from China can be difficult, and the FDA rarely seeks charges against consumers for personal use, he said. The FDA said it urges consumers to buy from licensed pharmacies and 'avoid products of unknown quality,' adding it was actively protecting consumers by intercepting illegal products at ports, and warning companies that market unapproved weight-loss medicines, including those mislabelled as 'for research purposes.' Although the forums show suppliers purportedly in China, Reuters was not able to verify where the drugs originate. None of the vendors responded to requests for comment. A Reddit spokesperson said the site prohibits facilitating transactions involving drugs and it had shut down a group found to be doing this. Telegram said it removes 'more than a million' instances of harmful content each day, but did not comment directly. Amy Spencer injects herself with obesity medication, which she purchased through the grey market, a new market for obesity drugs that allows consumers to purchase medication materials from China and reconstitute them into injectable drugs, at her home in southern Missouri April 24, 2025. — Reuters pic Microdose mistake Spencer has polycystic ovary syndrome and for years struggled with weight gain and hypertension. She decided to try obesity medicines after seeing claims on social media that microdosing them could give fewer side effects, and bought semaglutide, the active ingredient in Wegovy, from a compounding pharmacy for about US$200 per month. She started on one-fifth of the lowest dose. Within days, intermittent joint pain she often suffered had dissipated: 'I didn't realise how badly I hurt until the pain was gone.' The cost would reach about US$500 a month if she bought the drug from Novo, which recently introduced one-off discounts. After a week, Spencer said, her blood pressure dropped so low she thought she might pass out, so she stopped taking hypertension medicine. Her pressure stabilised and she lost three pounds. She wanted to understand more about microdosing, and turned to the grey market last summer. On Reddit, users told how another Novo drug in development, called CagriSema, had helped reduce inflammation and hunger pangs better than semaglutide. CagriSema is Novo's next-generation obesity drug candidate, still in clinical trials so not available to the public. It combines semaglutide with another molecule, called cagrilintide, which intensifies the hormone-mimicking effects to regulate blood sugar and reduce hunger. Spencer was intrigued. She found a US reseller saying they tested Chinese-made CagriSema through a third-party lab before selling it to Americans. On microdoses of CagriSema, Spencer could enjoy food in small quantities. 'I could say 'yes' because I knew I was only going to eat four bites.' In October, Spencer saw on Reddit that tirzepatide might also reduce inflammation. She placed a new order for vials that contained cagrilintide and tirzepatide combined, dubbed 'cagri-tirz.' Now each Monday, Spencer injects herself with tiny amounts of cagri-tirz. On Thursdays, she uses retatrutide, a new obesity medicine by Lilly, also in trials. As she was switching to cagri-tirz, Spencer made a dangerous mistake. She calculated her new dosage without realising the concentration of cagrilintide in the combined vials was 10 times higher than she had taken previously. 'I was an idiot. I didn't do my math. Or rather, I did the math for the tirzepatide but not for the cagri,' she said. Almost immediately, she began vomiting. The reaction was so severe she had trouble moving. She forced herself to drink water but couldn't eat. After four days, when symptoms lifted, she had lost seven pounds. Despite the blunder, Spencer didn't consider returning to compounded versions of the drugs or abandoning them altogether. She is not regularly monitored by a healthcare provider, but says her treatment has led to a 'life-changing' reduction in weight, joint pain and blood pressure. Marie, who asked to be identified by her middle name, filters reconstituted obesity medication, which was purchased through the grey market, a new market that allows consumers to purchase obesity medication materials from China and reconstitute them into injectable drugs, in the US Midwest April 28, 2025. — Reuters pic 'Honour system' Grey-market buyer Marie, 41, shows how do-it-yourself drugmakers are organising. She describes herself as a 'football mom' from the Midwest and asked to be identified by her middle name to protect her privacy. Last year she bought a compounding pharmacy's version of tirzepatide, paying about US$470 monthly, and had lost more than 20 pounds when the FDA announced the ban on compounded weight-loss drugs. She began to worry about her supply. Browsing on Reddit, she discovered links to Telegram and a trove of detailed instructions from experienced users for buying weight-loss drug ingredients from China. Customers said they often paid with Bitcoin or through mobile payment service Venmo. After a month closely following the forums, Marie made a purchase in January. The package that arrived contained 20 small glass vials of white powder with red caps. There were no instructions. The vendor who advertised the package on Telegram said it came from China. Marie returned to the forums and joined a group of 52 other customers who paid a total of US$1,020 to a Tennessee-based company called Peptide Test. Six members mailed in a vial each and the others chipped in their share of the fee. The lab found the samples were pure. Peptide Test declined to comment. 'It's an honour system,' said Marie. 'These groups are very supportive in a way I haven't seen on the internet before.' Marie, who asked to be identified by her middle name, stores obesity medication, which was purchased through the grey market, a new market that allows consumers to purchase obesity medication materials from China and reconstitute them into injectable drugs, in a deep freezer, in the US Midwest April 28, 2025. — Reuters pic Before her first injection, Marie gave her husband details of what she had done. They agreed that if needed, he would disclose everything to the emergency medics. But she was fine. In March, Marie volunteered to organise testing a new order of tirzepatide. The group formed on Telegram after users received vials from the same vendor which they judged to be from the same batch based on the colour of the caps. In all, 38 buyers agreed to chip in for the US$1,300 bill, and decided by poll that five vials would be enough. Five people sent drugs to the lab, Janoshik Analytical in the Czech Republic, which found the vials contained tirzepatide, as purported, with purity between 99.78 per cent and 99.85 per cent. Janoshik's CEO, Peter Magic, is a former amateur weight-lifter. He said his company started out more than a decade ago testing performance-enhancing drugs for online buyers. Last year, it tested 3,050 samples of obesity drugs, up from just over 650 samples in 2023. 'We're testing hundreds of these every week,' said Magic, whose company helps customers navigate customs requirements for shipping chemicals. — Reuters
Malay Mail
a day ago
- Malay Mail
‘Not a god': Arguments end in Combs trial ahead of deliberations
NEW YORK, June 28 — Sean 'Diddy' Combs's lawyer aimed yesterday to skewer the credibility of the music mogul's accusers, saying in closing arguments they were out for money while rejecting any notion he led a criminal ring. But in their rebuttal—the trial's final stage before jurors are tasked with deciding the verdict—prosecutors tore into the defense, saying Combs's team had 'contorted the facts endlessly.' Prosecutor Maurene Comey told jurors that by the time Combs—once among the most powerful people in music—had committed his clearest-cut offenses, 'he was so far past the line he couldn't even see it.' 'In his mind he was untouchable,' she told the court. 'The defendant never thought that the women he abused would have the courage to speak out loud what he had done to them.' 'That ends in this courtroom,' she said. 'The defendant is not a god.' For most of Friday's hearing defense attorney Marc Agnifilo picked apart, and even made light of, the testimony of women who were in long-term relationships with Combs, and who said he had coerced them into drug-fueled sex parties with paid escorts. Agnifilo scoffed at the picture painted by prosecutors of a violent, domineering man who used his employees, wealth and power to foster 'a climate of fear' that allowed him to act with impunity. Combs, 55, is a 'self-made, successful Black entrepreneur' who had romantic relationships that were 'complicated' but consensual, Agnifilo said. In his freewheeling, nearly four-hour-long argument, Agnifilo aimed to confuse the methodic narrative US attorney Christy Slavik provided one day prior. She had spent nearly five hours meticulously walking the jury through the charges and their legal basis, summarizing thousands of phone, financial, travel and audiovisual records along with nearly seven weeks of testimony from 34 witnesses. Central to their case is the claim that Combs led a criminal enterprise of senior employees—including his chief-of-staff and security guards—who 'existed to serve his needs.' But Agnifilo underscored that none of those individuals testified against Combs, nor were they named as co-conspirators. 'This is supposed to be simple,' the defense counsel told jurors. 'If you find that you're in the weeds of this great complexity, maybe it's because it just isn't there.' If convicted, Combs faces upwards of life in prison. 'Brazen' Casandra Ventura and a woman who testified under the pseudonym Jane described abuse, threats and coercive sex in excruciating detail. Combs's defense has conceded that domestic violence was a feature of the artist's relationships, but that his outbursts did not amount to sex trafficking. The defense insisted the women were consenting adults. Prosecutor Comey snapped back that they were being 'manipulated' into 'brazen' acts of sex trafficking, reiterating once again for jurors what the government says are the clearest-cut examples. Agnifilo pointed to Ventura's civil lawsuit against Combs in which she was granted US$20 million: 'If you had to pick a winner in this whole thing, it would be Cassie,' he said. Comey called that notion insulting: 'What was her prize? Black eyes? A gash in her head? Sex for days with a UTI?' The prosecutor also pointed to a violent episode between Combs and Jane, when she says she struck him in an argument before he brutally beat her, knocked her down in the shower, and then forced her into giving an escort oral sex. 'Jane may have started that fight, but he finished it with a vengeance,' Comey said, calling that incident the most obvious sex trafficking case and saying he had 'literally beaten her into submission.' Throughout the trial, jurors were shown voluminous phone records, including messages of affection and desire from both women—and Agnifilo emphasized the love and romance once again. Both prosecutors said taking those words literally, and in isolation, doesn't paint the whole picture. They also referenced testimony from a forensic psychologist who explained to jurors how victims become ensnared by abusers. 'The defense is throwing anything they can think of at the wall, hoping something will stick,' Comey said. On Monday, Judge Arun Subramanian will instruct jurors on how to apply the law to the evidence for their deliberations. Then, 12 New Yorkers will determine Combs's future. But Combs's legal worries may not end there, after three new sexual assault lawsuits were filed against him this week. One was by a woman who alleged the rapper's son, Justin, lured her from the southern state of Louisiana to Los Angeles where she was held captive, drugged and gang raped by three masked men in 2017. One of the men was allegedly Sean Combs. The other two cases were filed by men who accuse the rapper and his team of drugging and sexually assaulting them at parties in 2021 and 2023. — AFP
